Form 8-K - Current report:
SEC Accession No. 0001193125-20-203443
Filing Date
2020-07-30
Accepted
2020-07-30 08:33:21
Documents
15
Period of Report
2020-07-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58779d8k.htm   iXBRL 8-K 29390
2 EX-99.1 d58779dex991.htm EX-99.1 63649
7 GRAPHIC g58779img1.jpg GRAPHIC 11222
  Complete submission text file 0001193125-20-203443.txt   284150

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20200730.xsd EX-101.SCH 4547
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20200730_def.xml EX-101.DEF 13773
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20200730_lab.xml EX-101.LAB 22821
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20200730_pre.xml EX-101.PRE 14742
8 EXTRACTED XBRL INSTANCE DOCUMENT d58779d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 201059352
SIC: 2836 Biological Products, (No Diagnostic Substances)